COVID-19 Pneumonia in Patients on Chronic Hydroxychloroquine Therapy: Three Cases of COVID-19 Pneumonia
| Autor: | Adam Purdy, Peter T. Ender, Awan Rahman |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty 2019-20 coronavirus outbreak Coronavirus disease 2019 (COVID-19) business.industry Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 030106 microbiology COVID-19 Hydroxychloroquine Case Report Infectious and parasitic diseases RC109-216 General Medicine medicine.disease Virus respiratory tract diseases 03 medical and health sciences Pneumonia 0302 clinical medicine Internal medicine medicine In patient 030212 general & internal medicine business medicine.drug |
| Zdroj: | Case Reports in Infectious Diseases Case reports in infectious diseases, 2020:8822753 Case Reports in Infectious Diseases, Vol 2020 (2020) |
| ISSN: | 2090-6633 2090-6625 |
| Popis: | Hydroxychloroquine has gained popularity as a potential preventative and treatment of COVID-19 pneumonia due to its in vitro activity against the virus. These three cases of COVID-19 pneumonia of varying severities occurred in the setting of chronic hydroxychloroquine use. These cases argue against the use of hydroxychloroquine as a preventative or therapeutic option for COVID-19 pneumonia. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text